Salbutamol dry-powder inhalation - Vectura

Drug Profile

Salbutamol dry-powder inhalation - Vectura

Alternative Names: Albuterol Clickhaler; Asmasal Clickhaler; Salbutamol Clickhaler

Latest Information Update: 21 May 2013

Price : $50

At a glance

  • Originator Innovata
  • Developer Vectura
  • Class Antiasthmatics; Antibronchitics; Bronchodilators; Ethanolamines; Phenethylamines; Small molecules; Tocolytics
  • Mechanism of Action Beta 2 adrenergic receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Marketed Asthma

Most Recent Events

  • 13 May 2013 Salbutamol Clickhaler licensed to Tianjin Kinnovata Pharmaceutical in China
  • 13 May 2013 Vectura plans clinical trials for Asthma in China
  • 19 Jan 2007 Innovata has been acquired by Vectura
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top